Vortex Biosciences: Funding, Investors & Team (Sep 2026)
Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering and informatics to deliver better tools for isolating and characterizing circulating tumor cells (CTCs). Vortex’s first product, the VTX-1 Liquid Biopsy System, automates the label free isolation and collection of viable CTCs directly from whole blood.
Vortex Biosciences has raised $6.5M across 2 funding rounds on record, the most recent an undisclosed round of $4.1M announced in Jun 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vortex Biosciences Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Vortex Biosciences Funding Rounds
Vortex Biosciences raised $2.4M in a Debt Financing announced in Aug 2022.
10 months later, an undisclosed round of $4.1M was announced in Jun 2023.
Vortex Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Vortex Biosciences Funding Compared to Other Biotechnology Startups
Vortex Biosciences' latest round of $4.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vortex Biosciences in Biotechnology and Menlo Park
Companies Similar to Vortex Biosciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Vortex Biosciences Funding FAQs
What does Vortex Biosciences do?
Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering and informatics to deliver better tools for isolating and characterizing circulating tumor cells (CTCs). Vortex’s first product, the VTX-1 Liquid Biopsy System, automates the label free isolation and collection of viable CTCs directly from whole blood.
How much funding has Vortex Biosciences raised?
Vortex Biosciences has raised $6.5M across 2 rounds on record. The most recent is an undisclosed round of $4.1M announced in Jun 2023.
When did Vortex Biosciences last raise funding?
Vortex Biosciences' most recent funding round on record is an undisclosed round of $4.1M, announced in Jun 2023.
Who founded Vortex Biosciences?
FundedIQ lists Elodie Sollier (Founder) at Vortex Biosciences.
Where is Vortex Biosciences headquartered?
Vortex Biosciences is based in Menlo Park, California, United States.
How many employees does Vortex Biosciences have?
Vortex Biosciences is in the 11-50 employee band.
How does Vortex Biosciences' funding compare to other Biotechnology startups?
Vortex Biosciences' latest round of $4.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Vortex Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vortex Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.